Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

11551

1

Barinthus Biotherapeutics plc. Barinthus Biotherapeutics Reports Mixed Financial Results, Shifts Focus to Key Product Candidates

Via official filing (AI summary) | 7 months ago | 0 comments

11552

1

BlackRock TCP Capital Corp. BlackRock TCP Capital Corp. Reports Significant Financial Developments Following Merger with BlackRock Capital Investment Corporation

Via official filing (AI summary) | 7 months ago | 0 comments

11553

1

Scienture Holdings, Inc. Scienture Holdings Reports Significant Financial Changes, Including 83% Revenue Decline and 337% Operating Expense Increase in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11554

1

CONDUENT Inc Conduent Reports 13% Revenue Decline, Turnaround in Profitability in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11555

1

Coya Therapeutics, Inc. Coya Therapeutics Reports 9-Month Financial Results, Collaboration Revenue Growth, and Strategic Advancements in Clinical Programs

Via official filing (AI summary) | 7 months ago | 0 comments

11556

1

Coupang, Inc. Coupang Reports 27% Revenue Growth, Operating Income Increase in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11557

1

NewAmsterdam Pharma Co N.V. NewAmsterdam Pharma Reports 890% Revenue Growth, Improved Operating Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11558

1

UroGen Pharma Ltd. UroGen Pharma Reports Increased Revenue and Assets, Widening Losses in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11559

1

Praxis Precision Medicines, Inc. Praxis Precision Medicines Reports Significant Financial Developments, Increased Cash Reserves, and Ongoing Operating Losses

Via official filing (AI summary) | 7 months ago | 0 comments

11560

1

Paysign, Inc. Paysign, Inc. Reports 23% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11561

1

AMERICAN ELECTRIC POWER CO INC American Electric Power Reports Strong Financial Performance in Q3 2024, with Revenues and Net Income Up

Via official filing (AI summary) | 7 months ago | 0 comments

11562

1

LENZ Therapeutics, Inc. LENZ Therapeutics Reports Improved Liquidity, Reduced Losses Following Merger and PIPE Financings

Via official filing (AI summary) | 7 months ago | 0 comments

11563

1

Tango Therapeutics, Inc. Tango Therapeutics Reports Revenue Growth, Increased Expenses, and Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11564

1

Lantheus Holdings, Inc. Lantheus Holdings Reports 18.4% Revenue Growth to $378.7 Million in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11565

1

VISHAY INTERTECHNOLOGY INC Vishay Intertechnology Reports Significant Revenue and Profit Declines in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11566

1

Dine Brands Global, Inc. Dine Brands Global Reports Decline in Revenues and Profitability in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11567

1

Latham Group, Inc. Latham Group Reports Mixed Q3 Results Amid Challenging Market Conditions

Via official filing (AI summary) | 7 months ago | 0 comments

11568

1

RAND CAPITAL CORP Rand Capital Corporation Reports Strong Financial Performance in Q3 2024, with Increased Investment Income and Net Asset Value

Via official filing (AI summary) | 7 months ago | 0 comments

11569

1

Lineage, Inc. Lineage, Inc. Reports Mixed Q3 2024 Results, Net Loss Widens Amid Higher Operating Expenses and Strategic Developments

Via official filing (AI summary) | 7 months ago | 0 comments

11570

1

Katapult Holdings, Inc. Katapult Holdings Reports 10% Revenue Growth, Widened Losses in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11571

1

Immunocore Holdings plc Immunocore Holdings plc Reports 23.7% Revenue Growth, Strong Cash Reserves in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11572

1

STARWOOD PROPERTY TRUST, INC. Starwood Property Trust Reports Mixed Q3 Results, Net Income Up 40% Amid Revenue Decline

Via official filing (AI summary) | 7 months ago | 0 comments

11573

1

CVS HEALTH Corp CVS Health Reports 6.3% Revenue Growth, 96.9% Decline in Net Income in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11574

1

National Vision Holdings, Inc. National Vision Holdings Reports Mixed Financial Results, Strategic Developments for Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11575

1

MASIMO CORP Masimo Corporation Reports Mixed Q3 Results, Healthcare Segment Growth Offset by Non-Healthcare Decline

Via official filing (AI summary) | 7 months ago | 0 comments